Table 2.
A description of the individual cases. All patients are male. All ventricular tachycardia (VT) ablations performed were endocardial procedures unless otherwise specified
| Patient | Age (years) | CMP type | LVEF (%) | AAD at admission (daily dosage) | Previous VT ablation | Presentation with | VT CL (ms) | Clinical context for resorting to autonomic modulation |
|---|---|---|---|---|---|---|---|---|
| 1 | 69 | Ischaemic | 15 |
Amiodarone 200 mg Carvedilol 12.5 mg |
Yes | Recurrent VT | 510 | Patient refused to undergo repeat CA with mechanical circulatory support in the setting of recurrent haemodynamically not tolerated slow VT |
| 2 | 51 | Ischaemic | 10 |
Amiodarone 400 mg Metoprolol 150 mg |
No | Recurrent VT | 476 | CA deferred because technical difficulties were expected due to severe LV dilatation (LV end-diastolic diameter of 90 mm) |
| 3 | 62 | Non-ischaemic | 45 |
Amiodarone 200 mg Bisoprolol 10 mg |
No | Recurrent VT | 390 | Strong suspicion of an epicardiac substrate with difficult access expected due to morbid obesity (BMI 43). Subtherapeutic amiodarone levels |
| 4 | 73 | Ischaemic | 34 |
Amiodarone 300 mg Metoprolol 200 mg |
Yes | Recurrent VT | 508 | Left-sided septal substrate with both a mechanical mitral valve prosthesis and a calcified aortic valve which could not be passed during a previous CA |
| 5 | 69 | Ischaemic | 47 | Amiodarone 200 mg | Yes | Electrical storm | 275 | Recent unsuccessful CA: mid-myocardial septal substrate could not be reached from either the LV or the RV |
| 6 | 75 | Ischaemic | 26 |
Amiodarone 400 mg Metoprolol 50 mg |
Yes | Electrical storm | 450 | Multiple clinical VT morphologies. Recent CA with successful ablation of a mid-inferior VT. The other clinical VTs were not inducible, although four other non-clinical VTs with haemodynamic instability were induced |
| 7 | 74 | Ischaemic | 36 |
Amiodarone 300 mg Metoprolol 200 mg |
Yes | Electrical storm | 367 | Recent unsuccessful endocardial CA due to an epicardiac basal inferior substrate. Previous CABG |
| 8 | 74 | Ischaemic | 43 | Sotalol 160 mg | Yes | Electrical storm | 310 | Electrical storm during elective CA with immediate reinitiation of VT. Exit could not be identified periprocedurally during ongoing resuscitation |
| 9 | 77 | Ischaemic | 42 | Sotalol 240 mg | Yes | Electrical storm | 306 | CA deferred due to significant comorbidity (amiodarone pneumonitis, cognitive impairment, hairy cell leukaemia) |
| 10 | 71 | Non-ischaemic | 38 |
Amiodarone 400 mg Metoprolol 200 mg |
Yes | Recurrent VT | 420 | Three previous CAs of VT exits near mechanical aortic valvular prosthesis (trans-septal approach) and at the LV crux (through the great cardiac vein using both cryoablation and alcohol) |
| 11 | 71 | Ischaemic | 31 | Sotalol 160 mg | Yes | Electrical storm | 360 | Recent substrate ablation of an inferoposterolateral scar with uncertainty whether the substrate was endo- or epicardiac. Opted for PSGB to allow for loading with amiodarone |
| 12 | 85 | Non-ischaemic | 20 | Bisoprolol 10 mg | No | Electrical storm | 280 | CA deferred due to frailty and a poor functional capacity |
CMP cardiomyopathy, LVEF left ventricular ejection fraction, AAD antiarrhythmic drugs, CL cycle length, CA catheter ablation, BMI body mass index, LV left ventricle, RV right ventricle, CABG coronary artery bypass grafting